RU2022101386A - The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection) - Google Patents

The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection) Download PDF

Info

Publication number
RU2022101386A
RU2022101386A RU2022101386A RU2022101386A RU2022101386A RU 2022101386 A RU2022101386 A RU 2022101386A RU 2022101386 A RU2022101386 A RU 2022101386A RU 2022101386 A RU2022101386 A RU 2022101386A RU 2022101386 A RU2022101386 A RU 2022101386A
Authority
RU
Russia
Prior art keywords
cov
sars
prevention
treatment
infection
Prior art date
Application number
RU2022101386A
Other languages
Russian (ru)
Inventor
Шахноз Садыковна Азимова
Талат Саатович Саатов
Баходир Равилович Зайнутдинов
Ойбек Норбой Аширов
Собирджан Анарматович Сасмаков
Елена Лысова
Артем Александрович Махнев
Мукаддас Рустамовна Умарова
Умида Бахриддин Кизи Хамидова
Галина Александровна Пиякина
Джалолиддин Мирджамилович Абдурахманов
Шухрат Шавкатович Хасанов
Фарход Бакир Эшбоев
Original Assignee
Мусаханова Ойгуль Мирзаюсуфовна
Filing date
Publication date
Application filed by Мусаханова Ойгуль Мирзаюсуфовна filed Critical Мусаханова Ойгуль Мирзаюсуфовна
Publication of RU2022101386A publication Critical patent/RU2022101386A/en

Links

Claims (4)

1. Применение лекарственного средства, содержащее в липосомах эффективное количество молекул РНКазы А, для профилактики или лечения коронавирусной инфекции, вызываемой SARS-CoV-2 для интраназального или ингаляционного введения.1. The use of a medicinal product containing an effective amount of RNase A molecules in liposomes for the prevention or treatment of coronavirus infection caused by SARS-CoV-2 for intranasal or inhalation administration. 2. Применение комбинированного лекарственного средства, содержащее в липосомах эффективное количество молекул РНКазы А с никлозамидом, для профилактики или лечения коронавирусной инфекции, вызываемой SARS-CoV-2.2. The use of a combined drug containing in liposomes an effective amount of RNase A molecules with niclosamide for the prevention or treatment of coronavirus infection caused by SARS-CoV-2. 3. Применение по п.2 для интраназального или ингаляционного введения.3. Use according to claim 2 for intranasal or inhalation administration. 4. Способ профилактики или лечения SARS-CoV-2 инфекции, в котором молекулы РНКазы А с никлозамидом, содержащиеся в эффективном количестве в липосомах комбинированного лекарственного средства вводятся одновременно, отдельно или последовательно. 4. A method for preventing or treating SARS-CoV-2 infection, wherein RNase A molecules with niclosamide contained in an effective amount in liposomes of a combination drug are administered simultaneously, separately or sequentially.
RU2022101386A 2022-01-21 The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection) RU2022101386A (en)

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2021119487A Division RU2021119487A (en) 2021-07-02 2021-07-02 Combination drug with antiviral effect for the prevention of infection with SARS-CoV-2

Publications (1)

Publication Number Publication Date
RU2022101386A true RU2022101386A (en) 2023-07-21

Family

ID=

Similar Documents

Publication Publication Date Title
RU2020123893A (en) ESKETAMIN FOR THE TREATMENT OF DEPRESSION
JP2002104963A (en) Inhalable aerosol medicament for treatment or prevention of pain
ES2369547T8 (en) PROCEDURE FOR THE TREATMENT OF HUMAN DISEASES ASSOCIATED WITH A HIGH CONTENT OF DEOXIRRIBONUCLEIC ACID IN THE EXTRACELLULAR SPACES OF THE FABRICS AND MEDICAL PREPARATION TO CARRY OUT SUCH PROCEDURE.
FR2910327B1 (en) USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR TREATING PAIN INDUCED BY THERAPEUTIC TREATMENTS OF AIDS VIRUS.
EA022840B1 (en) Pharmaceutical composition, kit, use thereof and method for prophylactics and treatment of a symptom, condition or disease associated with infection by an influenza virus
RU2006139819A (en) APPLICATION OF SYMETICON FOR PATIENTS POSITIONED FOR CONSTIPATION
RU2022101386A (en) The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection)
CN105311081A (en) Application of Shanhaidan chrysanthemum indicum injection in aerosol inhalation, spray bottle aerial fog and rectal administration and method
RU2021119487A (en) Combination drug with antiviral effect for the prevention of infection with SARS-CoV-2
DE59408028D1 (en) Medicinal product containing capsaicin for the treatment of chronic rhinopathy
RU2002120894A (en) A method for the treatment of post-inflammatory bullous keratopathy
SUGAI et al. Effect of nitrous oxide alone or its combination with fentanyl on spinal reflexes in cats
Kuang et al. Study on combined acupunture with general anesthesia in pneumonectomy
RU2229877C1 (en) Agent for influenza treatment
RU2020123217A (en) Anti-SARS-CoV-2 virus agent Antiprovir
CN107095884A (en) A kind of Eradicates necrotic tissue and promoting muscle growings cream
RU2180532C2 (en) Method for treating the cases of papillomatosis
CN116763853A (en) Formula for inhibiting brain and eye diseases
RU2082451C1 (en) Method for restoring working capacity and treating patients possessing general somatic diseases
Sadovsky Hyperbaric oxygen therapy in the care of infectious disease
RU2189820C1 (en) Method for treating bronchial asthma
WO2021242191A1 (en) A mixture for corona virus (covid-19) disease
RU2021133726A (en) COMPOSITIONS AND METHODS FOR POTENTIATION OF 4-AMINOPHENOL DERIVATIVES
RU2020122037A (en) Method for the treatment of acute respiratory viral infection
RU2022106854A (en) Method of administration of the drug intranasally